Cohere’s soaring ARR reignites IPO speculation
Enterprise AI company Cohere is again at the center of market speculation as industry insiders suggest the startup is on track to surpass $240 million in annual recurring revenue (ARR), a milestone that could position it for a potential public listing in 2026.
Founded by former Google Brain researchers, Cohere has emerged as one of the most closely watched providers of large language models (LLMs) for businesses. Unlike consumer-facing AI chatbots, the company focuses on embedding AI capabilities directly into enterprise workflows, from customer support and search to document automation and knowledge management.
Enterprise-first AI strategy drives growth
Cohere has built its reputation on an enterprise-first approach, prioritizing data privacy, security and deployment flexibility. Its models can be run in the cloud, in a customer’s virtual private cloud, or on-premises, a key differentiator for heavily regulated industries such as finance, healthcare and the public sector.
Analysts note that this positioning has helped the company sign large multi-year contracts, contributing to its rapidly climbing ARR. As enterprises move beyond experimentation and into full-scale AI adoption, vendors able to meet strict compliance and governance requirements are seeing the fastest revenue acceleration.
Could 2026 be Cohere’s IPO window?
The prospect of a Cohere IPO in 2026 will depend on several factors: the health of the broader technology and capital markets, the company’s ability to sustain high double-digit or triple-digit revenue growth, and competitive pressure from rivals in the generative AI ecosystem.
Market observers point out that if Cohere continues to scale its recurring revenue and demonstrates a clear path to profitability, it could become one of the flagship public offerings of the next AI wave. A successful listing would not only validate its enterprise-focused model but also provide fresh capital to invest in AI research, infrastructure and global expansion.
While no formal timeline has been announced, the combination of surging ARR, deep enterprise relationships and intense investor interest suggests that 2026 is emerging as a plausible target year for Cohere to test the public markets.